Xuanzhu Biopharmaceutical Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 2575?
Owner Type	Number of Shares	Ownership Percentage
Individual Insiders	9,435,200	1.82%
Institutions	30,697,915	5.93%
General Public	67,333,500	13%
VC/PE Firms	70,032,855	13.5%
Private Companies	84,216,106	16.3%
Public Companies	256,232,214	49.5%

Dilution of Shares: 2575 only recently listed within the past 12 months

Top Shareholders

Top 20 shareholders own 87% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
49.1%	Sihuan Pharmaceutical Holdings Group Ltd.	254,451,414	HK$8.6b	0%	no data
13.5%	CS Capital Co., Ltd.	70,032,855	HK$2.4b	0%	no data
6.96%	Tianjin Zhenxuan Pharmaceutical Technology Partnership (Limited Partnership)	36,049,144	HK$1.2b	0%	no data
4.51%	SDIC Innovation Investment Management Co., Ltd.	23,344,465	HK$791.4m	0%	3.43%
2.52%	Beihai Baimeien Investment Partnership (Limited Partnership)	13,039,600	HK$442.0m	0%	no data
2.25%	Shijiazhuang Keshuo Investment Centre (Limited Partnership)	11,672,143	HK$395.7m	0%	no data
1.63%	Beihai Jixin Xuanzhu Investment Partnership (Limited Partnership)	8,466,510	HK$287.0m	0%	no data
1.42%	Beijing Tonghe Yinxing Innovative Asset Management Centre (Limited Partnership)	7,353,450	HK$249.3m	0%	no data
0.91%	Yanjun Xu	4,714,400	HK$159.8m	0%	no data
0.74%	Beihai Keya Xuanzhu Investment Partnership (Limited Partnership)	3,849,190	HK$130.5m	0%	no data
0.58%	Jiakui Li	3,020,800	HK$102.4m	0%	no data
0.57%	Tianjin Hongzekang Pharmaceutical Technology Partnership (Limited Partnership)	2,969,200	HK$100.7m	0%	no data
0.48%	Tianjin Xuansheng Pharmaceutical Technology Partnership (Limited Partnership)	2,485,600	HK$84.3m	0%	no data
0.37%	Tianjin Hongteng Pharmaceutical Technology Partnership (Limited Partnership)	1,919,600	HK$65.1m	0%	no data
0.34%	Beijing SL Pharmaceutical Co., Ltd.	1,780,800	HK$60.4m	0%	no data
0.33%	Cheng-Kon Shih	1,700,000	HK$57.6m	0%	no data
0.22%	Shanghai Yunxin Venture Capital Management Co., Ltd.	1,152,319	HK$39.1m	0%	no data
0.19%	Tianjin Pusheng Pharmaceutical Technology Partnership (Limited Partnership)	999,200	HK$33.9m	0%	no data
0.18%	Tianjin Guoding Pharmaceutical Technology Partnership (Limited Partnership)	958,000	HK$32.5m	0%	no data
0.13%	Tianjin Huize Pharmaceutical Technology Partnership (Limited Partnership)	655,600	HK$22.2m	0%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/10/18 06:19
End of Day Share Price	2025/10/17 00:00
Earnings	2025/06/30
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Xuanzhu Biopharmaceutical Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.